| Literature DB >> 23365164 |
Archana A Kshirsagar1, Christopher J D Reid, Jayanthi Alamelu, Manish D Sinha.
Abstract
A 5-year-old boy presented with neutropenia 9 weeks following the administration of rituximab for management of his steroid-dependent nephrotic syndrome. Extensive investigations failed to identify any underlying cause. In keeping with adult reports, rituximab was thought to be the likely cause for this 'late-onset' neutropenia (LOP). He was treated successfully with granulocyte-colony-stimulating factor. Patients treated with rituximab need to be carefully monitored for LOP.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23365164 PMCID: PMC3604382 DOI: 10.1136/bcr-2012-007958
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X